Experimental Treatment for Sézary Syndrome Earns Fast Track Designation
skeeze / Pixabay

Experimental Treatment for Sézary Syndrome Earns Fast Track Designation

According to a story from pm360online.com, the drug developer Innate Pharma SA recently announced that its experimental therapy IPH4102 has been granted Fast Track designation from the US Food and…

Continue Reading Experimental Treatment for Sézary Syndrome Earns Fast Track Designation

A Recap on 2018: Record Number of Drugs Approved by the FDA for Rare Diseases

Each year the Food and Drug Administration approves dozens of new therapies to fulfill unmet needs for various patient populations. It's just been published that in 2018 they approved a…

Continue Reading A Recap on 2018: Record Number of Drugs Approved by the FDA for Rare Diseases
Close Menu